This study explores colorectal cancer providers’ views on patient eligibility for subsequent treatment following the diagnosis of a cancer that has come back (recurrent) in order to further evaluate the role of treatment eligibility in a patient centered surveillance plan. This study aims to solicit clinician input regarding these and other factors that deemed to be clinically relevant such as co-existing medical conditions and competing causes of death.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02321488.
Locations matching your search criteria
United States
Texas
Houston
M D Anderson Cancer CenterStatus: Active
Contact: George Jae-Shik Chang
Phone: 713-792-6940
PRIMARY OBJECTIVES:
I. Determine the surveillance practice patterns following curative resection of colorectal cancer.
II. Identify patient characteristics related to eligibility for treatment after the detection of a colorectal cancer recurrence.
OUTLINE:
Participants complete a survey related to surveillance practice patterns following curative resection of colorectal cancer patients.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationM D Anderson Cancer Center
Principal InvestigatorGeorge Jae-Shik Chang
